Pluristem's PLX-R18 Shows Meaningful Advantage Over Other Treatments In Transplant Patients
March 23, 2022 at 12:35 PM EDT
Pluristem Therapeutics Inc(NASDAQ: PSTI)announced final resultsfrom its hematology Phase 1 study of intramuscular ...